Fabros, Loreta .
HRN: 23-01-67 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
CEFTAZIDIME 1GM (VIAL)
06/01/2023
06/07/2023
IV
1gm
Q8
Pneumonia
Waiting Final Action